Effect of Dapoxitine, Paroxetine, Combination therapy of Dapoxetine/Tadalafil and Combination therapy of Paraoxytine/Tadalafil in premature ejaculatio
Phase 3
- Conditions
- Premature Ejaculation.Premature ejaculationF52.4
- Registration Number
- IRCT20190528043747N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 120
Inclusion Criteria
Married men aged between 20 to 50 years
IELT less than 2 minutes
Having at least 1 sexual intercourse in a week
Exclusion Criteria
Having underlying disease including diabetes, hypertension, heart disease, thyroid disease, sexually transmitted disease, and psychiatric disease
Treated with any psychiatric medication
Erectile dysfunction
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cured Premature Ejaculation. Timepoint: Evaluation of Premature Ejaculation, Two and Four Weeks after Treatment. Method of measurement: Improved or not Improved Intravaginal Ejaculation Latency Time (Two Minutes) measured by the individual.
- Secondary Outcome Measures
Name Time Method